+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Bone and Joint Health Supplements Market - Growth, Trends and Forecast (2020 - 2025)

  • ID: 4617270
  • Report
  • April 2020
  • Region: Global
  • 110 pages
  • Mordor Intelligence
until Jun 30th 2020
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now


  • Amway
  • Bayer AG
  • Nature’s Bounty Co
  • Pfizer
  • Procter & Gamble
  • VitaScience
  • MORE
Global Bone and Joint Health Supplements Market is projected to grow at a CAGR of 6.6% during the forecasted period (2019-2024).

Owing to a rise in the population of baby boomers, along with the growing prevalence of lifestyle diseases associated with aging, the market is set to witness a significant growth following the above-mentioned considerations. The consolidated aging population across countries, such as Japan and Germany, among others, is one of the key demographics that is expected to propel the demand further.

Over the past years, the sports and fitness industry has witnessed large participation from the millennial addressing the need for active lifestyles on a regular basis. This segment of demographics is anticipated to scale the demand for bone and joint supplement since most of the prescribed supplements are a result of undertaking steps toward a preventive measure.

Key Market Trends

Significant Volume Of Demand Solely From The Ageing Population

The market studied primarily thrives on the aging population that is highly susceptible to bone injuries and fractures. The geriatric population is the largest target audience for bone and joint health supplement manufacturers, worldwide. Rheumatoid arthritis is one of the most common autoimmune diseases faced by the global population. The rising number of patients for osteoporosis and rheumatoid arthritis is leading the manufacturers to produce collagen-based candies, supplements, and drinks, which, when orally-consumed, deliver sufficient results. The aging process naturally makes consumers aware of their bone health. Furthermore, the aging population is aspiring for ease of movement and joint comfort, and this has given a substantial push to the market studied.nuThe World Health Organization (WHO) has estimated that almost 22 million individuals in Europe and 14 million in the United States alone will be suffering from osteoporosis. In 2017, it was observed that more than 200 million people suffered from osteoporosis. These alarming figures have given significant momentum to the market studied.

United States Holds The Major Share In North America Bone And Joint Supplement Market

The healthcare expenditure in United states is rising everyday, with growing aged population, advanced technology, advanced pharmacies distribution channel, better medical facilities, and rise in the number of insured people. These factors are driving the bone and joint health supplements market in the country. Moreover, calcium is one of the most on-demand supplements among women in USA, with growing aged population, arthritis cases, and other bone and joint diseases. In the recent past, there has been a steady increase in incidences of lifestyle diseases, due to hectic schedules, as well as changing lifestyle patterns. Thus, the consumers are taking preventive measures for reducing the effects of lifestyle diseases.

Competitive Landscape

The bone and joint health market supplements market is expected to be highly competitive in the future, owing to the increasing demand of these supplements across various age groups, so as to prevent early bone disorders. North America holds a dominating share in the global bone and joint health supplements market followed by Europe.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown
2 of 4


  • Amway
  • Bayer AG
  • Nature’s Bounty Co
  • Pfizer
  • Procter & Gamble
  • VitaScience
  • MORE
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Drivers
4.2 Market Restraints
4.3 Porter's Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry

5.1 By Type
5.1.1 Vitamin D
5.1.2 Vitamin K
5.1.3 Calcium
5.1.4 Collagen
5.1.5 Glucosamine-Chondroitin
5.1.6 Omega-3 Fatty Acid
5.1.7 Other Types
5.2 By Distribution Channel
5.2.1 Supermarkets/Hypermarkets
5.2.2 Pharmacies
5.2.3 Health Stores
5.2.4 Convenience Stores
5.2.5 Internet Retailing
5.2.6 Other Distribution Channels
5.3 Geography
5.3.1 North America United States Canada Mexico Rest of North America
5.3.2 Europe Spain United Kingdom France Germany Russia Italy Rest of Europe
5.3.3 Asia Pacific China Japan Australia India Rest of Asia-Pacific
5.3.4 South America Brazil Argentina Rest of South America
5.3.5 Middle East and Africa South Africa United Arab Emirates Rest of Middle East and Africa

6.1 Most Active Companies
6.2 Most Adopted Strategies
6.3 Market Share Analysis
6.4 Company Profiles
6.4.1 Amway
6.4.2 Pfizer
6.4.3 Bayer AG
6.4.4 Reckitt Benckiser Group plc
6.4.5 Xtend-Life
6.4.6 VitaScience
6.4.7 Procter & Gamble
6.4.8 Nature’s Bounty Co

Note: Product cover images may vary from those shown
3 of 4


4 of 4
  • Amway
  • Pfizer
  • Bayer AG
  • Reckitt Benckiser Group plc
  • Xtend-Life
  • VitaScience
  • Procter & Gamble
  • Nature’s Bounty Co
Note: Product cover images may vary from those shown